Imricor Medical Systems Q2 2026 Financial Results
Key points
- Net loss of $7.4 million for Q2 2026
- Total revenue for Q2 2026 was $60.5 million
- Cash and cash equivalents increased to $60.5 million
Full summary
Imricor Medical Systems, Inc. reported its financial results for the second quarter of 2026. The company reported a net loss of $7.4 million for the quarter, compared to a net loss of $5.7 million in the same period last year. Total revenue for Q2 2026 was $60.5 million, down from $65.2 million in Q2 2025. The company's cash and cash equivalents increased to $60.5 million as of June 30, 2026, from $19.5 million as of December 31, 2025. The company's total assets stood at $73.6 million as of June 30, 2026, compared to $45.8 million as of December 31, 2025.
Summary generated by a large language model. Please interpret with care.